A Systematic Review of Laser Treatment for Angiofibromas in Tuberous Sclerosis.

ABSTRACT:

Background

While mammalian target of rapamycin inhibitors have revolutionized the management of angiofibroma in tuberous sclerosis complex (TS), physical modalities such as laser are still indicated for recalcitrant lesions.

Objective

The authors performed a systematic review of the efficacy and safety of laser treatment for TS-related facial angiofibroma.

Methods

The electronic databases such as MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, and Web of Science were searched from inception to October 10, 2023, for eligible records.

Results

Forty-seven articles met the inclusion criteria, representing a total of 217 patients with TS-related facial angiofibroma who received laser treatment. Several lasers have been trialed in patients in

SUBMITTER: Gu Y 

PROVIDER: S-EPMC11350175 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature